“Leadership in Phytomedicine: From Farm to Pharma”

Dr. Arun Chandan’s Strategic Contributions to Medicinal Plant Cultivation and Phytopharmaceutical Innovation

---

Dr. Arun Chandan: Leading the Future of Phytomedicine through Genotype-Based Cultivation and Academic Innovation

Dr. Arun Chandan, a seasoned Ayurvedic medico-specialist, researcher, and policy advisor, has been at the forefront of transforming India’s medicinal plant sector by integrating traditional wisdom with modern phytopharmaceutical science. His pioneering work has established a strong foundation for phytomedicine research, standardization, and farmer-oriented innovation across the country—particularly in the northern states under the Regional Cum Facilitation Centre for Medicinal Plants (RCFC NR-1) framework.

---

Identifying the Challenge: Why Cultivating Medicinal Plants Was Not Paying Off

Through extensive fieldwork across Himachal Pradesh, Punjab, Haryana, and Uttarakhand, Dr. Chandan identified that thousands of farmers were dissatisfied with the returns from cultivating medicinal plants despite government schemes and rising herbal demand.

Key issues observed:

• Lack of genotype-specific cultivation: Farmers were using random seeds or non-authenticated planting material.
• Unstable phytochemical profiles: Resulting in rejection by buyers due to non-compliance with pharmacopoeial or industry standards.
• No access to soil-crop suitability data: Mismatch of species with agro-climatic zones led to crop failure or low yield.
• Low awareness of chemotype-based pricing: Industry buys based on bioactive content, not just bulk volume.

---

Strategic Response: Promoting Genotype and Chemotype-Specific Cultivation

Dr. Chandan emphasized that scientific cultivation must be driven by genotype and chemotype precision. In medicinal plants, the same species may have different chemotypes based on geographic, genetic, and environmental factors—each with unique therapeutic or commercial value.

Key Concepts Promoted:

• Genotype: The genetic constitution of the plant; determines its capacity to produce specific phytoconstituents.
• Chemotype: The chemical profile of a plant variety; e.g., citral-rich vs. geraniol-rich Lemongrass.
• Eco-type: Regionally adapted genotypes based on soil, water, and microclimate conditions.

Recommended Cultivation Practices:

• Use of QPM (Quality Planting Material) from accredited nurseries.
• Adoption of soil testing, slope orientation, and seasonal sowing calendars.
• Establishment of community nurseries with tagged, certified varieties.
• Promotion of species-specific Good Agricultural Practices (GAP) and Good Field Collection Practices (GFCP).

These interventions were institutionalized through RCFC NR-1’s agrotechnology protocols and training modules for farmers and FPOs.

---

Academic Leap: MSc in Phytomedicine at BFUHS, Faridkot

Recognizing the urgent need for trained scientific manpower, Dr. Arun Chandan conceptualized and was instrumental in launching the MSc in Phytomedicine at Baba Farid University of Health Sciences (BFUHS), Faridkot, Punjab, with visionary support from Vice Chancellor Dr. Rajiv Sood.

This unique postgraduate program addresses the interface between classical Ayurveda and modern phytochemistry, with modules on:

• Ayurvedic Materia Medica and Dravyaguna
• Phytochemical Extraction & Marker-Based Standardization (HPTLC, HPLC, GC-MS)
• Plant Pharmacognosy and Toxicology
• Phytopharmaceuticals under CDSCO regulations
• Clinical Research and Product Formulation

The course is also designed to serve the phytopharmaceutical industry, nutraceutical sector, and export markets by building a trained workforce for:

• R&D labs
• Ayurvedic medicine manufacturing
• Herbal quality testing and regulatory affairs
• Clinical validation and IPR documentation

---

Farm to Pharma Vision: Real-World Impacts

With a multi-pronged approach, Dr. Chandan’s initiatives have already created measurable impacts:

For Farmers:

• Access to authenticated planting material from Center of Excellence nurseries.
• Higher returns from chemotype-specific buybacks.
• Training in cultivation + post-harvest management = reduced wastage and improved quality.

For Industry:

• Reliable, traceable supply of standardized raw material.
• Encouragement of contract farming models with phytochemical thresholds.
• Expansion of plant-based APIs for export and clinical trials.

For Education & Research:

• India’s first MSc Phytomedicine program as a replicable model.
• Opportunities for PhD research in genotype evaluation, ethnobotany, and Ayurveda pharmaceutics.
• Integration with LokAyurved initiatives for validation of folk healers’ knowledge.

---

Future Directions: What Dr. Arun Chandan Envisions

1. Geo-tagged cultivation zones mapped by genotype and chemotype potential.
2. Establishment of State-level Genotype Catalogues and Open Access Plant Databases.
3. Promotion of phytopharmaceutical clusters in Ayurveda hubs like Dharamsala, Dehradun, and Varanasi.
4. Integration of genome analysis, AI tools, and IOT sensors for Ayurvedic agritech solutions.
5. Global branding of Indian phytomedicine through traceable, validated, export-compliant plant products.

---

A Model for India’s Herbal Economy

Dr. Arun Chandan’s work is a benchmark for 21st-century Ayurveda and herbal enterprise. By focusing on genotype validation, chemotype cultivation, academic capacity building, and clinical relevance, he has connected the dots between farmers, healers, scientists, regulators, and entrepreneurs. His vision ensures that India does not just cultivate herbs—but cultivates science, trust, and global leadership in phytomedicine.